| dc.contributor.author | Varma, S S | |
| dc.contributor.author | Aiswarya, S U | |
| dc.contributor.author | Keerthana, C K | |
| dc.contributor.author | Rayginia, T P | |
| dc.contributor.author | Induja, D K | |
| dc.contributor.author | Anto, R J | |
| dc.contributor.author | Lankalapalli, R S | |
| dc.date.accessioned | 2023-11-04T12:06:02Z | |
| dc.date.available | 2023-11-04T12:06:02Z | |
| dc.date.issued | 2023-09-01 | |
| dc.identifier.citation | Tetrahedron Letters; 127:154668 | en_US |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0040403923003787?via%3Dihub | |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/4576 | |
| dc.description.abstract | Uttroside B from Solanum nigrum Linn. exhibited potent cytotoxicity against HepG2 cells with an IC50 of 0.5 μM; interestingly, its congeners uttroside A and uttronin exhibited the same level of activity. We hypothesized that spirocyclization is the critical step for the activity of uttroside A or B that results in the formation of uttronin. To support our hypothesis, an uttroside B analogue was synthesized that cannot undergo spirocyclization, which resulted in a loss of cytotoxic activity. Mass spectral analysis of the supernatant from the cells treated with uttroside B further supported the spirocyclization of uttroside B to uttronin. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.subject | solanum nigrum | en_US |
| dc.subject | uttroside B | en_US |
| dc.subject | uttronin | en_US |
| dc.subject | degalactotigonin | en_US |
| dc.subject | spirocyclization | en_US |
| dc.subject | prodrug | en_US |
| dc.title | Putative role of uttronin (degalactotigonin) in cytotoxicity of uttroside B in HepG2 cells | en_US |
| dc.type | Article | en_US |